EUPROBIO 2008
PRELIMINARY CONFERENCE PROGRAMME
WSTĘPNY PROGRAM KONFERENCJI
(click here - kliknij tutaj)
(click here - kliknij tutaj)
|
Please note! The conference fee includes participation in all conference sessions and workshops including social events
according to the program, conference materials, conference bag with accessories as well as all meals and drinks during the conference. Presentation timing is listed in square brackets. Szanowni Państwo! Opłata konferencyjna obejmuje uczestnictwo we wszystkich sesjach i warsztatach zjazdu łącznie imprezami towarzyszącymi wg programu, materiały konferencyjne,
torbę zjazdową z akcesoriami oraz wszystkie posiłki i napoje serwowane podczas konferencji. Czas prezentacji został podany w kwadratowych nawiasach. |
|
Wednesday, October 15
Środa, 15 października 10:00 Polish Society for Probiotics and Prebiotics General Assembly / Zgromadzenie Ogólne Członków Polskiego Towarzystwa Probiotycznego i Prebiotycznego 12:00 Reception and registration opens / Otwarcie recepcji i rejestracji Authors requested to start placing their posters at 8:00 the following day (on Thursday, October 16, 2008) Autorzy proszeni o wieszanie plakatów w kolejnym dniu od godz. 8:00 (w czwartek, 16 października 2008 r.) 17:00 Official opening / Ceremonia otwarcia Prof. Piotr B. Heczko, President of the Polish Society for Probiotics and Prebiotics 17:15 Opening Session 1. Prof. Gregor Reid, President of International Scientific Association for Probiotics and Prebiotics Probiotics at the crossroads: where do the paths lead? 2. Prof. Stanisław Konturek, President of the Polish Physiological Society Melatonin as an integrating molecule in the gut 3. Prof. Ernst R. Weissenbacher, President of the European Society for Infectious Diseases in Obstetrics and Gynaecology The importance of immunology in Ob/Gyn 19:00... Get-together cocktail and buffet with live music/ Wieczór zapoznawczy z poczęstunkiem i muzyką na żywo Thursday, October 16
Czwartek, 16 października 8:00 Reception and registration opens / Otwarcie recepcji i rejestracji Authors requested to place their posters Autorzy proszeni o wieszanie plakatów 9:00 Plenary session 1 / Sesja plenarna 1 Probiotics, immunity, novel & experimental works – Probiotyki, odporność, prace nowatorskie i eksperymentalne Chair: Prof. Joseph Rafter 1. Prof. Alexander Swidsinski (Germany) Mucus barrier, intestinal flora, inflammation and probiotics [30’] 2. Dr James Versalovic (USA) Probiotics and mechanisms of immunomodulation [40’] 3. Prof. Joseph Rafter (Sweden) Probiotics and regulation of fat storage [30’] 4. Dr Magdalena Strus (Poland) The double faces of Lactobacillus in Inflammatory Bowel Disease [20’] 11:00 Coffee break / Przerwa na kawę 11:30 Plenary session 1 continues / Sesja plenarna 1 kontynuacja Short presentations Chair: Prof. Hanna Szajewska 5. Karlsson M, Lam S, Reid G, Jass J Lactobacillus rhamnosus GR-1 augments NF-κB and TNF in Escherichia coli-challenged human epithelium [10’] 6. Spivak N, Pidgorskyy V, Timoshok N, Lazarenko L, Shynkarenko-Sichel L Immune regulatory cytokines Del-Immune V® induction and its impact on cytotoxicity of natural killer cells [10’] 7. Cukrowska B, Rosiak I, Witosław U, Kozakova H, Schwarzer M, Szperl M The effect of non-pathogenic microbiota on the gut expression of TLR-2 and -4 [10’] 8. Poddar D, Kumar M, Raj D, Kapila S, Aggarwal PK Antiapoptotic effect of bioactive peptides derived from Lactobacillus rhamnosus GG milk on rat intestinal epithelial cells [10’] 9. So J-S, Lee C-G, Kwon H-K, Yi H-J, Chae C-S, Park J-A, Hwang K-C, Im S-H Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis [10’] 10. Urbanska AM, Bhathena J, Martoni C, Prakash S Oral delivery of microencapsulated Lactobacillus acidophilus live bacterial cells lowers intestinal inflammation in Apc(Min/+) mice [10’] 11. Grimoud J, Durand H, Theodorou V, Monsan P, Roques C In vitro screening of probiotics for anti-inflammatory and anti- proliferative effects in human gut [10’] 12. Jani UK Effect Of Oral Immunization Of Broiler Chicks with Lactobacillus jensenii, Chicken Strain, MTCC-7825 on Immune Response against Killed New Castle Disease Virus Vaccine [10’] 13:00 Lunch 13:45 Poster session / Sesja plakatowa 14:00 Plenary session 2 / Sesja plenarna 2 G.I. tract, allergy and paediatric applications of probiotics - Układ pokarmowy, alergia oraz zastosowania probiotyków w pediatrii Chair: Dr James Versalovic 1. Prof. Hanna Szajewska (Poland) Probiotics for paediatric gastrointestinal diseases: do we have enough evidence? [30’] 2. Prof. Tomasz Brzozowski (Poland) Role of probiotics in the mechanisms of gastrointestinal integrity [20’] 3. Dr Flavia Indrio (Italy) Effect of prebiotic and probiotic on gastrointestinal motility in preterm newborns [30’] 4. Dr Sophie Nutten (Switzerland) Probiotics and respiratory allergy [25’] Short presentations 5. Bisson JF, Messaoudi M, Durand H Effects of Probiotic Formulations on a Travelers’ Diarrhea Model in Rats [15’] 6. Cukrowska B, Ceregra A, Rosiak I, Kozakova H, Czarnowska E, Schwarzer M, Motyl I, Klewicka E, Śliżewska K, Libudzisz Z Anti-allergic features of novel probiotic Lactobacillus casei and paracasei strains [10’] 7. Schrezenmeir J, Guillemard E, Tangy J, Flavigny AL, de la Motte S Consumption of a fermented dairy drink containing the probiotic Lactobacillus casei DN-114 001 reduces the risk of common infections in shift workers [10’] 8. Ruszczyński M, Radzikowski A, Szajewska H Randomized controlled trial: Effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy, and Pen) in the prevention of antibiotic-associated diarrhea in children [10’] 16:20 Coffee break / Przerwa na kawę 16:50 Plenary session 3 / Sesja plenarna 3 Probiotics & technology – Probiotyki & technologia Chair: Prof. Kasipathy Kailasapathy 1. Prof. Kasipathy Kailasapathy (Australia) Protection and delivery of probiotic bacteria in functional food and nutraceutical development [30’] 2. Dr Claude Champagne (Canada) The stability and use of dried probiotics in foods [30’] 3. Dr Douwina Bosscher (Belgium) Food based strategies to modulate the composition of the microbiota and their associated health effects [30’] Short presentations 4. Harel M, Tang J, Kyle D High Humidity and Temperature Resistant MicroMatrix - A Novel Encapsulation System for Probiotic Bacteria [10’] 5. Goderska K, Czarnecki Z Changes of intestinal microflora during digestion of microencapsulated Lactobacillus in model of gastrointestinal tract [10’] 6. Thantsha MS, Cloete TE, Moolman FS, Labuschagne PW, Van Der Merwe T, Mputle I Interpolymer complex encapsulation of Bifidobacteria: Effect on survival in simulated gastric and intestinal fluids and on their shelf life [10’] 7. Grozdanov L, Karaivanova E, Rumyan N Selective media for cultivation of lactic acid bacteria capable of respiratory metabolism [10’] 8. Oyetayo VO Probiotic properties of Lactobacillus species isolated from two fermented African beverages [10’] 9. Surono IS, Lukito W Functionality of Indigenous probiotic from dadih and regulatory aspects of Probiotic in Indonesia [10’] 19:20 Discussion and summary of the day / Dyskusja i podsumowanie dnia Friday, October 17
Piątek, 17 października 8:00 Reception opens / Otwarcie recepcji 8:30 Workshops / Warsztaty led by - prowadzący: Dr Sharon Hillier (USA), Prof. Per-Anders Mårdh (Sweden), Prof. Krzysztof Tomasz Niemiec (Poland), Dr Daniel Rönnqvist (Sweden) - THE? vaginal flora/ Wszystko o mikroflorze pochwy - Bacterial vaginosis today/ Bakteryjna waginoza dzisiaj - Viruses, chlamydia and mycoplasma in gynaecology / Wirusy, chlamydie i mykoplasmy w praktyce ginekologicznej - Laboratory assesment of vulvovaginal candidiasis / Laboratoryjna ocena kandydozy pochwy i sromu 11:00 Coffee break / Przerwa na kawę 11:30 Plenary session 4 / Sesja plenarna 4 Probiotics and gynaecology Chair: Prof. Gregor Reid 1. Dr Sharon Hillier (USA) Replacing Endogenous Lactobacilli in Women to Prevent Infections: Why We Need It and Why It Has Been a Challenge [30’] 2. Dr Paola Mastromarino (Italy) Antiviral activity of vaginal lactobacilli towards genital tract viruses [30’] 3. Prof. Per-Göran Larsson (Sweden) Probiotic treatments of Bacterial vaginosis [30’] Short presentations 4. Niemiec T, Jędrzejczyk S, Wilczyńska A, Wieczorek M, Kłosiński W, Jabłonowska E Bacterial vaginosis among HIV positive women [10’] 5. Daroczy K Characterisation of four probiotic lactic acid bacteria for human vaginal use - in-vitro probiotic properties and vaginal colonisation ability [10’] 6. Mikołajczyk-Cichońska A IBSS BIOMED SA – An Expert in Probiotics [10’] 13:30 Lunch 13:50 Poster session / Sesja plakatowa 14:00 Plenary session 5 / Sesja plenarna 5 Probiotics and gynaecology Chair: Dr Sharon Hillier 1. Prof. Gregor Reid (Canada) How do vaginal probiotics function, and how can they benefit women in the developed AND developing world? [30’] 2. Dr Gilbert Donders (Belgium) Different types of abnormal vaginal flora as candidates for prophylactic treatment with probiotics [30’] 3. Dr Daniel Rönnqvist (Sweden) Prevention of recurrent vulvo-vaginal candidiasis – selection, identification and characterisation of a potential probiotic Lactobacillus strain [30’] Short presentations 4. Hummelen R, Changalucha J, Butamanya N, Cook A, Habbema JDF, Reid G The potential immune stimulatory effects of probiotics among persons infected with HIV in Mwanza, Tanzania [10’] 5. Ehrström S, Rylander E, Daroczy K, Johannesson U, Anzén B, Påhlson C Local probiotics: Colonization of the vagina and the influence of the rate of recurrence of yeast infections and bacterial vaginosis [10’] Awards for best posters and presentations funded by the Polish Society for Probiotics and Prebiotics Nagrodzenie najlepszych plakatów i wystąpień (nagrody ufundowane przez Polskie Towarzystwo Probiotyczne i Prebiotyczne) 16:00 Coffee break / Przerwa na kawę 16:15 Plenary session 6 / Sesja plenarna 6 Probiotics and safety – Probiotyki i bezpieczeństwo Chair: Dr Mary Ellen Sanders 1. Dr Mary Ellen Sanders (USA) Considerations for developing a safety dossier for probiotics [30’] 2. Prof. Bruno Pot (France) Selecting suitable strains for clinical trials: myth or reality? [30’] 3. Dr Vanessa Vankerckhoven (Belgium) Antibiotic resistance and transferability of resistance in probiotic bacteria [30’] 4. Prof. Piotr B. Heczko (Poland) Can probiotics be regarded as safe? [30’] 18:15 Final remarks & conclusions / Podsumowanie i wnioski Prof. Gregor Reid 18:30 Conference closure & sponsor thanks / Zakończenie konferencji i podziękowanie sponsorom Prof. Piotr B. Heczko |